These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9288066)

  • 1. Lisinopril and albumin excretion in diabetes.
    Pintavorn P; Rumsaeng V
    Lancet; 1997 Aug; 350(9078):663; author reply 663-4. PubMed ID: 9288066
    [No Abstract]   [Full Text] [Related]  

  • 2. Lisinopril and albumin excretion in diabetes.
    Williams B
    Lancet; 1997 Aug; 350(9078):662; author reply 663-4. PubMed ID: 9288063
    [No Abstract]   [Full Text] [Related]  

  • 3. Lisinopril and albumin excretion in diabetes.
    Sawicki PT
    Lancet; 1997 Aug; 350(9078):662; author reply 663-4. PubMed ID: 9288064
    [No Abstract]   [Full Text] [Related]  

  • 4. Lisinopril and albumin excretion in diabetes.
    van Guldener C; Donker AJ
    Lancet; 1997 Aug; 350(9078):662-3; author reply 663-4. PubMed ID: 9288065
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group.
    Lancet; 1997 Jun; 349(9068):1787-92. PubMed ID: 9269212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUCLID study.
    Tripathi K
    Lancet; 1997 Oct; 350(9084):1102-3. PubMed ID: 10213576
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension.
    Sengul AM; Altuntas Y; Kürklü A; Aydin L
    Diabetes Res Clin Pract; 2006 Feb; 71(2):210-9. PubMed ID: 16112244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients.
    Tuominen JA; Ebeling P; Koivisto VA
    Diabetes Care; 1998 Aug; 21(8):1345-8. PubMed ID: 9702445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
    Sjølie AK; Chaturvedi N; Fuller J
    Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to treat the hypertensive diabetic patient.
    Fuller JH
    J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
    [No Abstract]   [Full Text] [Related]  

  • 12. Going out to detect incipient diabetic nephropathy rather than waiting until it has supervened--a reversal in policy.
    Parving HH
    Nephrol Dial Transplant; 1996 Sep; 11(9):1728-9. PubMed ID: 8918612
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
    Parving HH
    J Diabetes Complications; 1996; 10(3):133-5. PubMed ID: 8807457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When should ACE inhibitors be given to normotensive patients with IDDM.
    Wang PH
    Lancet; 1997 Jun; 349(9068):1782-3. PubMed ID: 9269206
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy: response to Tarnow et al.
    Cooper ME
    Diabetes Care; 2000 Dec; 23(12):1723-4. PubMed ID: 11128340
    [No Abstract]   [Full Text] [Related]  

  • 16. Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy.
    Nielsen FS; Rossing P; Gall MA; Smidt UM; Chen JW; Sato A; Parving HH
    Scand J Clin Lab Invest; 1997 Aug; 57(5):427-34. PubMed ID: 9279969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal dosing of renin-angiotensin-aldosterone system blockers for renal protection: a solved issue?
    Laverman GD; Bakker SJ; Navis GJ
    Diabetologia; 2009 Jun; 52(6):1217-8. PubMed ID: 19294362
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats.
    Wienen W; Richard S; Champeroux P; Audeval-Gerard C
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):31-6. PubMed ID: 11881063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes.
    Atmaca A; Gedik O
    Adv Ther; 2006; 23(4):615-22. PubMed ID: 17050503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney disease in diabetology: lessons from 2008.
    Schernthaner G
    Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.